| VITEK 2 Gram Negative Susceptibility card (AST-N350), IVD, REF 421037, 20 cards per carton.Z-2511-2017 · LON | Biomerieux Inc | Recall | May 22, 2017FDA classification date |
| VITEK 2 Gram Negative Susceptibility card (AST-GN67), IVD, REF 413399, 20 cards per carton.Z-2527-2017 · LON | Biomerieux Inc | Recall | May 22, 2017FDA classification date |
| BD Phoenix Automated Microbiology System - GN Ceftazidime/avibactam (0.25/4- 32/4ug/mL)K163637 · LON | Becton Dickinson & Company | 510(k) | Mar 21, 2017FDA decision date |
| VITEK 2 AST-GN Gentamicin (<=1 >=16 µg/mL)K163563 · LON | bioMerieux, Inc. | 510(k) | Mar 13, 2017FDA decision date |
| VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL)K161437 · LON | bioMerieux, Inc. | 510(k) | Feb 16, 2017FDA decision date |
| VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL)K161510 · LON | bioMerieux, Inc. | 510(k) | Feb 13, 2017FDA decision date |
| VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL)K163083 · LON | bioMerieux, Inc. | 510(k) | Feb 1, 2017FDA decision date |
| VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL)K163006 · LON | bioMerieux, Inc. | 510(k) | Jan 24, 2017FDA decision date |
| VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL)K161217 · LON | bioMerieux, Inc. | 510(k) | Jan 12, 2017FDA decision date |
| PhoenixSpec Calibrator & Kit is used to calibrate the PhoenixSpec & Phoenix AP Instruments. The instruments are then used to measure the turbidit…Z-0311-2017 · LON | Becton Dickinson & Co. | Recall | Oct 25, 2016FDA record creation date |
| PhoenixSpec AP Calibrator is used to calibrate the PhoenixSpec & Phoenix AP Instruments. The instruments are then used to measure the turbidity o…Z-0312-2017 · LON | Becton Dickinson & Co. | Recall | Oct 25, 2016FDA record creation date |
| VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL)K161227 · LON | bioMerieux, Inc. | 510(k) | Jul 20, 2016FDA decision date |
| VITEK 2 Gram Positive Susceptibility Test Cards (AST-P605), REF 22 325. 20 Cards/Kit. bioMerieux, Inc, Durham, North Carolina 27712.
VITEK 2 is a…Z-1596-2016 · LON | Biomerieux Inc | Recall | May 3, 2016FDA classification date |
| VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL)K152075 · LON | bioMerieux, Inc. | 510(k) | Apr 15, 2016FDA decision date |
| BD Phoenix Automated Microbiology System-Ertapenem 0.0625-8 mcg/mlK151320 · LON | Becton, Dickinson and Company | 510(k) | Jan 15, 2016FDA decision date |
| Rapid Neg BP Combo Panel Type 3; Catalog number B 1017-117.
MicroScan Rapid panels are designed for use in determining identification to the s…Z-0170-2015 · LON | Siemens Healthcare Diagnostics, Inc. | Recall | Nov 7, 2014FDA classification date |
| Rapid Neg Urine Combo Panel Type 1; Catalog number B 1017-167;
Siemens Material Number 10444652
MicroScan Rapid panels are designed for use i…Z-0171-2015 · LON | Siemens Healthcare Diagnostics, Inc. | Recall | Nov 7, 2014FDA classification date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTESM - TIGECYCLINE (0.313-4UG/ML) GPK142170 · LON | Becton, Dickinson and Company | 510(k) | Oct 28, 2014FDA decision date |
| VITEK 2 AST GP CEFTAROLINEK141149 · LON | bioMerieux, Inc. | 510(k) | Jun 20, 2014FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAROLINE (0.625-4 UG/ML)K140468 · LON | Becton, Dickinson and Company | 510(k) | Jun 2, 2014FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM TIGECYCLINE (0.25-16 UG/ML)K132909 · LON | Becton, Dickinson and Company | 510(k) | Feb 14, 2014FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- MEROPENEM (0.125-32 UG/ML)K132674 · LON | Becton, Dickinson and Company | 510(k) | Dec 27, 2013FDA decision date |
| VITEK 2 AST ST MEROPENEMK132507 · LON | bioMerieux, Inc. | 510(k) | Nov 15, 2013FDA decision date |
| VITEK 2 AST-ST TIGECYCLINEK131779 · LON | bioMerieux, Inc. | 510(k) | Oct 10, 2013FDA decision date |
| VITEK 2 AST ST MOXIFLOXACIN, VITEK 2 AST STREPTOCOCCUS MOXIFLOXACINK132573 · LON | bioMerieux, Inc. | 510(k) | Sep 13, 2013FDA decision date |